Evidence map›Paper›PMID 31066867›Full record

ArticleJAMA dermatology2019

Histologic Features Associated With an Invasive Component in Lentigo Maligna Lesions.

Angela Moreno, Esperanza Manrique-Silva, Amaya Virós, Celia Requena, Onofre Sanmartín, Víctor Traves, Eduardo Nagore

Open access · bronzeAbstract read
In one paragraph

Article in JAMA dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. International Dermoscopy Society consensus recommendations for the management of lentigo maligna.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Review
  2. Article
  3. A Clinical Perspective on Melanoma Overdiagnosis.The Australasian journal of dermatology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Lentigo Maligna: Clinical Presentation and Appropriate Management.Clinical, cosmetic and investigational dermatology · 2020
    Review
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Angela MorenoSchool of Medicine, Universidad Católica de Valencia San Vicente Mártir, València, Spain.
Esperanza Manrique-SilvaDepartment of Dermatology, Instituto Valenciano de Oncología, València, Spain.
Amaya VirósSkin Cancer and Ageing Laboratory, CRUK Manchester Institute, The University of Manchester, Manchester, United Kingdom.
Celia RequenaDepartment of Dermatology, Instituto Valenciano de Oncología, València, Spain.
Onofre SanmartínDepartment of Dermatology, Instituto Valenciano de Oncología, València, Spain.
Víctor TravesDepartment of Pathology, Instituto Valenciano de Oncología, València, Spain.
Eduardo NagoreSchool of Medicine, Universidad Católica de Valencia San Vicente Mártir, València, Spain.
Fundación Instituto Valenciano de Oncología · ESValencia Catholic University Saint Vincent Martyr · ESCancer Research UK Manchester Institute · GB

Funding

Wellcome Trust 110078/Z/15/Z
6 · The paper itself

Abstract

Importance: Lentigo maligna (LM) presents an invasive component in up to 20% of biopsied cases, but to date the histologic features useful in detecting this invasive component have not been described. Some histologic characteristics are hypothesized to contribute to the progression of LM invasion. Objective: To identify the histologic characteristics associated with lentigo maligna melanoma (LMM) in patients with LM diagnosed by a partial diagnostic biopsy. Design, Setting, and Participants: A retrospective cross-sectional study of patients treated between January 1, 2000, and December 31, 2017, was conducted in a referral oncology center in València, Spain. Data and specimens of patients (n = 96) with a diagnosis of primary cutaneous melanoma in the form of either LM or LMM who had undergone surgical treatment, a complete histologic examination of the whole tumor, and an initial diagnostic partial biopsy of LM were included in the study. Histologic assessment was blinded to the presence of an invasive component. Interventions: All biopsy specimens were evaluated for the presence of certain histologic characteristics. Main Outcomes and Measures: Comparisons between invasive samples and samples without an invasive component were performed. The differences in the distribution of variables between the groups were assessed using the χ2 and Fisher exact tests, and the degree of association of the relevant variables was quantified by logistic regression models. A classification and regression tree analysis was performed to rank the variables by importance. Results: In total, 96 patients had sufficient histologic material that could be evaluated. The patients were predominantly male (56 [58.3%]) and had a mean (SD) age at diagnosis of 72 (12) years. Of these patients, 63 (65.6%) had an LM diagnosis and 33 (34.4%) had an LMM diagnosis (an invasive component). The histologic variables associated with the presence of an invasive component were melanocytes forming rows (odds ratio [OR], 11.5; 95% CI, 1.4-94.1; P = .02), subepidermal clefts (OR, 2.8; 95% CI, 1.0-7.9; P = .049), nests (OR, 3.0; 95% CI, 1.1-8.6; P = .04), and a lesser degree of solar elastosis (OR, 0.4; 95% CI, 0.1-1.1; P = .07). A classification and regression tree analysis of the relevant histologic features was able to accurately identify lentigo maligna with an invasive component (LMM) in more than 60% of patients. Conclusions and Relevance: These findings may be useful in classifying early LM specimens at higher risk of invasion, which may eventually be relevant in identifying the most appropriate management for LM.

Indexed as

AgedAged, 80 and overBiopsyCross-Sectional StudiesDisease ProgressionFemaleHumansHutchinson's Melanotic FreckleMaleMelanocytesMelanomaMiddle AgedNeoplasm InvasivenessRetrospective StudiesSkin NeoplasmsSpain

Identifiers

PMID31066867
PMCPMC6506897
OpenAlexW2944534656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.